Fortis Healthcare (FORTIS) — Financial Results

Investor Takeaways

No financial results or guidance were disclosed in the filing

Market Cap of ₹72,751.54 Cr reflects current valuation

P/E Ratio of 94.57 indicates elevated valuation relative to peers

Overall Tone: Neutral based on the numbers only.

Key Financial Highlights

Metric	Value	YoY Change
Revenue	Not available	N/A
Net Profit	Not available	N/A
EBITDA	Not available	N/A
EPS	Not available
OPM	Not available

What Changed

The filing announces an investor and analyst meeting held on August 7, 2026 to discuss unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. However, the filing provides no financial figures, growth rates, or forward-looking statements. The audio recording of the meeting is available on the company's investor relations website. This absence of disclosed financial data limits the ability to assess performance or trajectory.

The company's current fundamentals show a market capitalization of ₹72,751.54 Cr and a P/E ratio of 94.57. These metrics are presented without context from the current period's results, making comparative analysis impossible based solely on this filing.

Peer Comparison

Company	P/E	ROE	ROCE	Market Cap (₹ Cr)
Fortis Healthcare	94.57	Not available	Not available	72,751.54
Sun Pharmaceutical Industries Limited	41.28	15.11%	20.34%	4,50,643.09
Divi's Laboratories Limited	72.41	16.56%	22.09%	1,79,470.03
Torrent Pharmaceuticals Limited	80.06	N/A	N/A	1,49,108.91

Fortis Healthcare's P/E ratio of 94.57 is significantly higher than Sun Pharmaceutical (41.28) and Divi's Laboratories (72.41), suggesting market expectations may be priced at a premium relative to these peers.

Risks & Concerns

No specific risks identified in this filing

Absence of financial results prevents assessment of operational performance or guidance

Quarterly Trend

Quarter	Revenue (₹ Cr)	Net Profit (₹ Cr)	OPM%
Q3FY25	1,928.26	254.3	19.45
Q2FY25	1,988.39	193.08	21.87
Q1FY25	1,858.9	173.98	18.43
Q4FY24	1,785.88	203.14	21.34

📄 View Original Announcement (PDF)

📊 Stock Analysis — FORTIS ✨ Ask AI About This

About Fortis Healthcare Limited (FORTIS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹68,550.2 Cr P/E: 65.4 ROE: 10.8% ROCE: 13.3% Div Yield: 0.11%

View full FORTIS stock details →

📡 Get AI alerts when FORTIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FORTIS — Free

💡 Ask AI about this filing

"When will the unaudited financial results for Q1 FY27 be released?" "What were the revenue and profit figures discussed in the call?" "How does the company's performance compare to peers in the healthcare sector?"

Ask AI Free →

📊 More FORTIS filings

See all FORTIS filings →

🔥 Also filed on 7 August 2026

OLAELEC Ola Electric Mobility Limited Financial Results NCC NCC Limited Financial Results GRWRHITECH Garware Hi-Tech Films Limited Financial Results ARVSMART Arvind SmartSpaces Limited Financial Results BEML BEML Limited Financial Results RUSTOMJEE Keystone Realtors Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FORTIS files new disclosures

Track FORTIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.